Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

ADDENDUM: Section E9 of the American College of Medical Genetics Technical Standards and Guidelines: Fluorescence in situ hybridization.

Mascarello JT, Hirsch B, Kearney HM, Ketterling RP, Olson SB, Quigley DI, Rao KW, Tepperberg JH, Tsuchiya KD, Wiktor AE; A Working Group of the American College of Medical Genetics (ACMG) Laboratory Quality Assurance Committee.

Genet Med. 2019 Oct;21(10):2405. doi: 10.1038/s41436-019-0508-z. No abstract available.

PMID:
31028353
2.

Generating a taxonomy for genetic conditions relevant to reproductive planning.

Korngiebel DM, McMullen CK, Amendola LM, Berg JS, Davis JV, Gilmore MJ, Harding CO, Himes P, Jarvik GP, Kauffman TL, Kennedy KA, Simpson DK, Leo MC, Lynch FL, Quigley DI, Reiss JA, Richards CS, Rope AF, Schneider JL, Goddard KA, Wilfond BS.

Am J Med Genet A. 2016 Mar;170(3):565-73. doi: 10.1002/ajmg.a.37513.

3.

Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencing.

Leo MC, McMullen C, Wilfond BS, Lynch FL, Reiss JA, Gilmore MJ, Himes P, Kauffman TL, Davis JV, Jarvik GP, Berg JS, Harding C, Kennedy KA, Simpson DK, Quigley DI, Richards CS, Rope AF, Goddard KA.

Am J Med Genet A. 2016 Mar;170(3):574-82. doi: 10.1002/ajmg.a.37477. Epub 2016 Jan 21.

4.

Cytogenetics caseload survey summary 2012.

Quigley DI, Foster JA, Carter SN, Wolff DJ.

J Assoc Genet Technol. 2012;38(4):199-202.

PMID:
23183332
5.

Section E9 of the American College of Medical Genetics technical standards and guidelines: fluorescence in situ hybridization.

Mascarello JT, Hirsch B, Kearney HM, Ketterling RP, Olson SB, Quigley DI, Rao KW, Tepperberg JH, Tsuchiya KD, Wiktor AE; Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee.

Genet Med. 2011 Jul;13(7):667-75. doi: 10.1097/GIM.0b013e3182227295.

PMID:
21738013
6.

Pharmacogenomic potential of psychiatric medications and CYP2D6.

Foley KF, Quigley DI.

MLO Med Lab Obs. 2010 Jan;42(1):32-4.

PMID:
20180465
7.

Analytical performance of the Investigational Use Only Cervista HPV HR test as determined by a multi-center study.

Day SP, Hudson A, Mast A, Sander T, Curtis M, Olson S, Chehak L, Quigley N, Ledford J, Yen-Lieberman B, Kohn D, Quigley DI, Olson M.

J Clin Virol. 2009 Jul;45 Suppl 1:S63-72. doi: 10.1016/S1386-6532(09)70010-1.

PMID:
19651371
8.

Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report.

Znoyko I, Stuart RK, Ellingham T, Winters J, Wolff DJ, Quigley DI.

Cancer Genet Cytogenet. 2008 May;183(1):64-8. doi: 10.1016/j.cancergencyto.2008.01.022.

PMID:
18474300
9.

Inverted and deleted chromosome 16 with deletion of 3'CBFB identified by fluorescence in situ hybridization.

Spencer DV, Cavalier M, Kalpatthi R, Quigley DI.

Cancer Genet Cytogenet. 2007 Nov;179(1):82-4. No abstract available.

PMID:
17981221
10.

The Prothrombin 20209C>T Sequence Variant: To Test or Not to Test.

Quigley DI, Booker JK, Wolff DJ.

J Assoc Genet Technol. 2007;33(2):1-3.

PMID:
17630471
11.

HER2 testing: a review of detection methodologies and their clinical performance.

Laudadio J, Quigley DI, Tubbs R, Wolff DJ.

Expert Rev Mol Diagn. 2007 Jan;7(1):53-64. Review.

PMID:
17187484
12.

Jumping translocation of 1q in BCR/ABL-positive acute lymphoblastic leukemia.

Bilic M, Quigley DI, Stuart RK, Wolff DJ.

Cancer Genet Cytogenet. 2007 Jan 1;172(1):90-1. No abstract available.

PMID:
17175389
13.

Pediatric T-cell acute lymphoblastic leukemia with aberrations of both MLL loci.

Quigley DI, Wolff DJ.

Cancer Genet Cytogenet. 2006 Jul 1;168(1):77-9.

PMID:
16772125
14.

Triploid mosaicism in a 45,X/69,XXY infant.

Quigley DI, McDonald MT, Krishnamuthy V, Kishnani PS, Lee MM, Haqq AM, Goodman BK.

Am J Med Genet A. 2005 Oct 1;138A(2):171-4.

PMID:
16152633
15.

A clinical report of a patient with two abnormal cell lines: 46,XX,del(21)(q22.1) and 47,XX,+3.

Quigley DI, Sailus J, Kaiser-Rogers K, Rao KW, Calikoglu M, Gold S, McCandless SE.

Am J Med Genet A. 2005 Jan 1;132A(1):101-5. Review.

PMID:
15580640
16.

Submicroscopic deletion 9(q34.3) and duplication 19(p13.3): identified by subtelomere specific FISH probes.

Quigley DI, Kaiser-Rogers K, Aylsworth AS, Rao KW.

Am J Med Genet A. 2004 Feb 15;125A(1):67-72. Review.

PMID:
14755469
17.

Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK.

Mol Pharmacol. 2001 Dec;60(6):1181-8.

PMID:
11723224
18.

Integrity of tritiated orphanin FQ/nociceptin: implications for establishing a reliable binding assay.

Quigley DI, Arttamangkul S, Allen RG, Grandy DK.

Peptides. 2000 Jul;21(7):1111-8.

PMID:
10998545
19.

Orphanin-FQ/nociceptin (OFQ/N) modulates the activity of suprachiasmatic nucleus neurons.

Allen CN, Jiang ZG, Teshima K, Darland T, Ikeda M, Nelson CS, Quigley DI, Yoshioka T, Allen RG, Rea MA, Grandy DK.

J Neurosci. 1999 Mar 15;19(6):2152-60.

20.

Orphanin FQ is the major OFQ1-17-containing peptide produced in the rodent and monkey hypothalamus.

Quigley DI, McDougall J, Darland T, Zhang G, Ronnekliev O, Grandy DK, Allen RG.

Peptides. 1998;19(1):133-9.

PMID:
9437745

Supplemental Content

Loading ...
Support Center